Beleave Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Beleave are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Beleave has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Beleave is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 12 M | |
| Total Cashflows From Investing Activities | -9 M |
Beleave |
Beleave Relative Risk vs. Return Landscape
If you would invest (100.00) in Beleave on September 1, 2024 and sell it today you would earn a total of 100.00 from holding Beleave or generate -100.0% return on investment over 90 days. Beleave is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Beleave, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Beleave Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Beleave's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Beleave, and traders can use it to determine the average amount a Beleave's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| BLEVF |
Based on monthly moving average Beleave is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Beleave by adding Beleave to a well-diversified portfolio.
Beleave Fundamentals Growth
Beleave Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Beleave, and Beleave fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Beleave Pink Sheet performance.
| Return On Equity | -1.27 | |||
| Return On Asset | -0.25 | |||
| Operating Margin | (3.87) % | |||
| Current Valuation | 5.66 K | |||
| Shares Outstanding | 566.37 M | |||
| Price To Earning | (4.44) X | |||
| Price To Book | 0 X | |||
| Price To Sales | 0.0002 X | |||
| Revenue | 2.37 M | |||
| EBITDA | (30.76 M) | |||
| Cash And Equivalents | 120.41 K | |||
| Debt To Equity | 2.44 % | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (9.47 M) | |||
| Earnings Per Share | (0.03) X | |||
| Total Asset | 23.61 M | |||
About Beleave Performance
By analyzing Beleave's fundamental ratios, stakeholders can gain valuable insights into Beleave's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Beleave has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Beleave has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Beleave Inc. operates as a medical cannabis company in Canada. The company sells its products through operating stores and online. Beleave operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.Things to note about Beleave performance evaluation
Checking the ongoing alerts about Beleave for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Beleave help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Beleave is not yet fully synchronised with the market data | |
| Beleave has some characteristics of a very speculative penny stock | |
| Beleave has a very high chance of going through financial distress in the upcoming years | |
| The company has a current ratio of 0.16, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Beleave until it has trouble settling it off, either with new capital or with free cash flow. So, Beleave's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Beleave sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Beleave to invest in growth at high rates of return. When we think about Beleave's use of debt, we should always consider it together with cash and equity. | |
| Beleave reported the revenue of 2.37 M. Net Loss for the year was (33.78 M) with profit before overhead, payroll, taxes, and interest of 816.46 K. | |
| Beleave has accumulated about 120.41 K in cash with (9.47 M) of positive cash flow from operations. |
- Analyzing Beleave's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Beleave's stock is overvalued or undervalued compared to its peers.
- Examining Beleave's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Beleave's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Beleave's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Beleave's pink sheet. These opinions can provide insight into Beleave's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Beleave Pink Sheet
If you are still planning to invest in Beleave check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Beleave's history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |